About Nitin Lifesciences Limited
Data last updated:
Nitin Lifesciences Limited is a public limited company based in Paonta Sahib, Himachal Pradesh, India, a subsidiary of Recipharm Holding India Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U73100HP2005PLC028049. Its GSTIN is 02AACCN0725G1Z3 (Himachal Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹23.41 Cr. It is led by directors including Vishal Gupta and Abhinav Arora.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rampur Ghat Road Paonta Sahib Dist. Sirmaur, Himachal Pradesh, India – 173025.
As per the financials filed for FY 2025, the company reported a revenue of ₹157.19 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹2.82 Cr (net margin -1.8%) and EBITDA of ₹63.25 Lakh (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 14% over five years.
The company has about 291 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nitin Lifesciences. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹4.27 Cr on record. Court records list 21 cases involving the company, including 12 filed by the company and 10 filed against it; 2 cases are pending. The company has 9 deals on record (8 secondary share transfers, 1 acquisition); the latest was in November 2023. Its 9 peer companies in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Elysium Pharmaceuticals Ltd with revenue of ₹159.55 Cr. The company has 16 MSME Form 1 returns on record between 2016 and 2024, listing 2,147 overdue payments to 49 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nitinlifesciences.com.
Company details
CIN history
Nitin Lifesciences has one previous CIN (Corporate Identification Number): L73100HP2005PLC028049. The current CIN is U73100HP2005PLC028049, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100HP2005PLC028049 | Current |
| L73100HP2005PLC028049 | Previous |
Contact details
Nitin Lifesciences Limited's registered office is in Paonta Sahib, Himachal Pradesh. Its website is nitinlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressRampur Ghat Road Paonta Sahib Dist. Sirmaur, Himachal Pradesh, India – 173025
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nitin Lifesciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Nitin Lifesciences operates one associated brand: Nitin Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CMO of small volume parenteral injectables | nitinlifesciences.com |
Business activity
The main business activity of Nitin Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nitin Lifesciences Limited, buy the company report.
Financials of Nitin Lifesciences Limited
FY 2025 filings availableNitin Lifesciences Limited reported revenue of ₹157.19 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹63.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | -1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nitin Lifesciences Limited, buy the company report.
Board of directors of Nitin Lifesciences Limited
Nitin Lifesciences has 4 current directors and 29 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Gupta | Director | 27 Sep 2023 | 3 Years 1 Months | Current |
| Abhinav Arora Also directs: SPL Packaging Limited Liability Partnership, Synokem Pharmaceuticals Limited, Kemsyn Lifesciences Private Limited and 2 more | Director | 27 Sep 2023 | 3 Years 1 Months | Current |
| Thomas Baby | Additional Director | 07 Jan 2025 | 1 Years 9 Months | Current |
| Sanjay Khurana | Director | 27 Sep 2023 | 3 Years 1 Months | Current |
Peer comparison
Nitin Lifesciences Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Elysium Pharmaceuticals Ltd | ₹159.55 Cr (FY 2024) | -26.0% | Vadodara, Gujarat, India | |||
| VHB Medi Sciences Limited | ₹159.28 Cr (FY 2025) | 14.0% | Kandivlai West, Maharashtra, India | |||
| Jenburkt Pharmaceuticals Ltd | ₹158.41 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Wardex Pharmaceuticals Private Limited | ₹158.1 Cr (FY 2025) | 8.0% | Chennai, Tamil Nadu, India | |||
| Nitin Lifesciences Limitedthis company | ₹157.19 Cr (FY 2025) | -₹2.82 Cr | -1.8% | 7.0% | 291 | Paonta Sahib, Himachal Pradesh, India |
| Wings Pharmaceuticals Pvt Ltd | ₹155.72 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India | |||
| Combitic Global Caplet Private Limited | ₹154.55 Cr (FY 2025) | 37.0% | New Delhi, Delhi, India | |||
| Medico Remedies Limited | ₹153.63 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Sanzyme Private Limited | ₹153.25 Cr (FY 2025) | -27.0% | Hyderabad, Telangana, India | |||
| D K Pharma Chem Private Limited | ₹153.13 Cr (FY 2024) | -33.0% | Badlapur, Maharashtra, India |
To see the full peer comparison of Nitin Lifesciences Limited, buy the company report.
Auditor
Nitin Lifesciences Limited is audited by S.R. BATLIBOI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. BATLIBOI & CO. | FY 2023 | 301003E/E300005 |
Shareholding
The shareholding of Nitin Lifesciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nitin Lifesciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Apr 2018 | 100173734 | Others | ₹30 Lakh | Open | |
| 15 Jul 1994 | 90060432 | Haryana Financial Corporation | ₹20 Lakh | Open | |
| 30 Mar 2013 | 10423653 | Daimler Financial Services India Private Limited | ₹20 Lakh | Satisfied | |
| 11 Feb 2008 | 10092707 | Director of Industries of Himachal Pradesh | ₹30 Lakh | Satisfied | |
| 30 Mar 2006 | 10001218 | State Bank of India | ₹8.7 Lakh | Satisfied |
To see the full charge records of Nitin Lifesciences Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Nitin Lifesciences Limited has 9 deals on record (8 secondary share transfers, 1 acquisition); the latest was in November 2023.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2023 | Acquisition | ₹116.76 Cr | Buyer: Synokem Pharmaceuticals Limited Seller: an individual |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: Recipharm Holding India Private Limited Seller: an individual |
| Jan 2018 | Secondary share transfer | Undisclosed | Buyer: Recipharm Holding India Private Limited Seller: 2 individuals |
| Apr 2016 | Secondary share transfer | Undisclosed | Buyer: Recipharm Holding India Private Limited Seller: 2 individuals |
| Apr 2016 | Secondary share transfer | Undisclosed | Buyer: Recipharm Holding India Private Limited , Recipharm Holding Limited, Recipharm Venture Fund AB Seller: 4 individuals |
To see the full deal history of Nitin Lifesciences Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nitin Lifesciences Limited has 21 court cases on record: 12 filed by Nitin Lifesciences, 10 filed against it. 2 cases are pending and 19 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 1 | 0 |
| District courts | 9 | 9 | 2 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Court case (CS (COMM.)) | Filed against the company by M/S Nitin Lifesciences Ltd | Pending |
| District court, North, Delhi | Court case (CS (COMM.)) | Filed by the company against M/S Igb Polymers Private Limited and 3 others | Pending |
| District court, West, Delhi | Civil suit | Filed against the company by Om Logistics Ltd | Disposed |
| High Court, HIMACHAL PRADESH | Court case (CO.P) | Filed by the company against Nitin Pharmaceuticals Pvt Ltd(Not Applicable) | Disposed |
| District court, Muzaffarpur, Bihar | Court case (Cr. Case Complaint (O)) | Filed against the company by State of Bihar Through MD Parwez Akhtar | Pending |
To see the full case history of Nitin Lifesciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Nitin Lifesciences Limited has 16 MSME Form 1 returns on record between 2016 and 2024, listing 2,147 overdue payments to 49 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 49)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sarthak Biotech Private Limited | |||
| Packlabs | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Nitin Lifesciences Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Nitin Lifesciences Limited has a workforce of 291 employees on its EPFO records as of Apr 03, 2024, across 2 active EPFO establishments.
GST
Nitin Lifesciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCN0725G1Z3 | Himachal Pradesh | Active | 01 Jul 2017 |
| 06AACCN0725G1ZV | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nitin Lifesciences Limited, buy the company report.
Recent activity
Nitin Lifesciences Limited has 31 board changes on record since 2011: 6 appointments and 25 cessations. The latest: Gajanan Mohan Shenoy ceased to be Additional Director on 31 May 2025.
39 earlier events are in the company report.
News
Frequently asked questions
Nitin Lifesciences is an active public limited company based in Paonta Sahib, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 March 2005 (21+ years old) and is registered under CIN U73100HP2005PLC028049.
Nitin Lifesciences has 4 current directors:
- Vishal Gupta - Director
- Abhinav Arora - Director
- Thomas Baby - Additional Director
- Sanjay Khurana - Director
The latest financial statements of Nitin Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nitin Lifesciences is 02AACCN0725G1Z3, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 06AACCN0725G1ZV (Haryana).
The CIN (Corporate Identification Number) of Nitin Lifesciences is U73100HP2005PLC028049. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nitin Lifesciences has 21 court cases on record: 12 filed by the company and 10 filed against it. 2 are pending. Most are in the high courts.
Nitin Lifesciences was incorporated on 03 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Nitin Lifesciences has 9 deals on record (8 secondary share transfers, 1 acquisition); the latest was in November 2023.
The peers of Nitin Lifesciences by revenue are Elysium Pharmaceuticals Ltd, VHB Medi Sciences Limited, Jenburkt Pharmaceuticals Ltd, Wardex Pharmaceuticals Private Limited, Wings Pharmaceuticals Pvt Ltd and 4 more, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gajanan Mohan Shenoy ceased to be Additional Director on 31 May 2025. Thomas Baby was appointed as Additional Director on 07 Jan 2025. Suresh Nagappa Ganachari ceased to be Additional Director on 11 Mar 2024. Nitin Lifesciences has 31 board changes on record in total.
Nitin Lifesciences has 16 MSME Form 1 returns on record between 2016 and 2024, listing 2,147 overdue payments to 49 micro and small suppliers. The latest return was filed on 16 Jun 2024.
Nitin Lifesciences can be reached through the website nitinlifesciences.com. Its registered office is in Paonta Sahib, Himachal Pradesh, India.